Angiotensin II signalling and calcineurin in cardiac fibroblasts: Differential effects of calcineurin inhibitors FK506 and cyclosporine A

Therapeutic Advances in Cardiovascular Disease

Volumn 6, Issue 1, 2012, Pages 5-14

  White, Michel ^a   Montezano, Augusto C ^b   Touyz, Rhian M ^c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

heart; immunomodulators; MAP kinase; signal transduction

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CALCINEURIN; COLLAGEN; CYCLINE; CYCLOSPORIN A; FIBRONECTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TACROLIMUS;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME ACTIVATION; FIBROBLAST; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; INFLAMMATION; INFORMATION PROCESSING; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION;

ANGIOTENSIN II; ANIMALS; CALCINEURIN; CELL PROLIFERATION; CYCLOSPORINE; FIBROBLASTS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; PHOSPHORYLATION; RATS; RATS, INBRED WKY; SIGNAL TRANSDUCTION; TACROLIMUS;

EID: 84856730362     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944711432901     Document Type: Article

References (46)

1. Akool S. Doller A. Babelova A. Tsalastra W. Moreth K. Schaefer L. et al. (2008) Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506. J Immunol 181: 2831–2845.
2. Balakumar P. Jagadeesh G. (2010) Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res 62: 365–383.
3. Barry S.P. Davidson S.M. Townsend P.A. (2008) Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 40: 2023–2039.
4. Barry S.P. Townsend P.A. (2010) What causes a broken heart–molecular insights into heart failure. Int Rev Cell Mol Biol 284: 113–179.
5. Becker J.W. Rotonda J. McKeever B.M. Chan H.K. Marcy A.I. Wiederrecht G. et al. (1993) FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. J Biol Chem 268:11335-11339.
6. Bierer B.E. Holländer G. Fruman D. Burakoff S.J. (1993) Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opin Immunol: 763–773.
7. Braun W. Kallen J. Mikol V. Walkinshaw M.D. Wüthrich K. (1995) Three-dimensional structure and actions of immunosuppressants and their immunophilins. FASEB J 9: 63–72.
8. Clerk A. Cullingford T.E. Fuller S.J. Giraldo A. Markou T. Pikkarainen S. et al. (2007) Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses. J Cell Physiol 212: 311–322.
9. de Mello W.C. (2011) Novel aspects of angiotensin II action in the heart. Implications to myocardial ischemia and heart failure. Regul Pept 166: 9–14.
10. Dandel M. Lehmkuhl H.B. Knosalla C. Hetzer R. (2010) Impact of different long-term maintenance immunosuppressive therapy strategies on patients’ outcome after heart transplantation. Transpl Immunol 23: 93–103.
11. Dengler T.J. Pober J.S. (2000) Cellular and molecular biology of cardiac transplant rejection. J Nucl Cardiol 7: 669–685.
12. Dong D. Duan Y. Guo J. Roach D.E. Swirp S.L. Wang L. et al. (2003) Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels. Cardiovasc Res 57: 320–332.
13. Fiedler B. Wollert K.C. (2004) Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc Res 63: 450–457.
14. Ikeda Y. Miura T. Sakamoto J. Miki T. Tanno M. Kobayashi H. et al. (2006) Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation. Basic Res Cardiol 101: 418–426.
15. Kajitani K. Fujihashi M. Kobayashi Y. Shimizu S. Tsujimoto Y. Miki K. (2008) Crystal structure of human cyclophilin D in complex with its inhibitor, cyclosporin A at 0.96-A resolution. Proteins 70: 1635–1639.
16. Kurdi M. Booz G.W. (2011) New take on the role of angiotensin II in cardiac hypertrophy and fibrosis. Hypertension 57: 1034–1038.
17. Kuwahara K. Nakao K. (2011) New molecular mechanisms for cardiovascular disease: transcriptional pathways and novel therapeutic targets in heart failure. J Pharmacol Sci 116: 337–342.
18. Lorenz K. Schmitt J.P. Schmitteckert E.M. Lohse M.J. ( 2009) A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med 15: 75–83.
19. Lunde I.G. Kvaløy H. Austbo B. Christensen G. Carlson C.R. (2011) Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes. J Appl Physiol 111: 1278–1289.
20. Matsuda S. Koyasu S. (2003) Regulation of MAPK signaling pathways through immunophilin-ligand complex. Curr Top Med Chem 3: 1358–1367.
21. Matsuda S. Shibasaki F. Takehana K. Mori H. Nishida E. Koyasu S. (2000) Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep 1: 428–434.
22. McCormack P.L. Keating G.M. (2006) Tacrolimus: in heart transplant recipients. Drugs 66: 2269–2279.
23. Molkentin J.D. (2000) Calcineurin and beyond: cardiac hypertrophic signaling. Circ Res 87: 731–738.
24. Montezano A.C. Callera G.E. Yogi A. He Y. Tostes R.C. He G. et al. (2008) Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol 28: 1511–1518.
25. Patel J.K. Kobashigawa J.A. (2007) Tacrolimus in heart transplant recipients: an overview. BioDrugs 21: 139–143.
26. Plath K.E. Grabbe J. Gibbs B.F. (2003) Calcineurin antagonists differentially affect mediator secretion, p 38 mitogen-activated protein kinase and extracellular signal-regulated kinases from immunologically activated human basophils. Clin Exp Allergy 33: 342–350.
27. Porter K.E. Turner N.A. (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123: 255–278.
28. Rana O.R. Saygili E. Meyer C. Gemein C. Krüttgen A. Andrzejewski M.G. et al. (2009) Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. J Mol Cell Cardiol 46: 568–578.
29. Rao A. (2009) Signaling to gene expression: calcium, calcineurin and NFAT. Nat Immunol 10: 3–5.
30. Sanchez-Perez I. Rodriguez-Hernandez C.J. Manguan-García C. Torres A. Perona R. Murguía J.R. (2004) FK 506 sensitizes mammalian cells to high osmolarity by modulating p 38 MAP kinase activation. Cell Mol Life Sci 61: 700–708.
31. Santana L.F. Chase E.G. Votaw V.S. Nelson M.T. Greven R. (2002) Functional coupling of calcineurin and protein kinase A in mouse ventricular myocytes. J Physiol 544: 57–69.
32. Seibert F. Behrendt C. Schmidt S. van der Giet M. Zidek W. Westhoff T.H. (2011) Differential effects of cyclosporine and tacrolimus on arterial function. Transpl Int 24: 708–715.
33. Smaili S.S. Stellato K.A. Burnett P. Thomas A.P. Gaspers L.D. (2001) Cyclosporin A inhibits inositol 1,4,5-trisphosphate-dependent Ca2+ signals by enhancing Ca2+ uptake into the endoplasmic reticulum and mitochondria. J Biol Chem 276: 23329–23340.
34. Tan W.Q. Wang J.X. Lin Z.Q. Li Y.R. Lin Y. Li P.F. (2008) Novel cardiac apoptotic pathway: the dephosphorylation of apoptosis repressor with caspase recruitment domain by calcineurin. Circulation 118: 2268–2276.
35. Touyz R.M. Fareh J. Thibault G. Schiffrin E.L. (1996 a) Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension 28: 797–805.
36. Touyz R.M. Sventek P. Larivière R. Thibault G. Fareh J. Reudelhuber T. et al. (1996 b) Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. Hypertension 27: 1090–1096.
37. Touyz R.M. Yao G. (2003) Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. J Cell Physiol 197: 326–335.
38. Wang S.S. Chou N.K. Chi N.H. Wu I.H. Chen Y.S. Yu H.Y. et al. (2008) Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus. Transplant Proc 40: 2607–2608.
39. Wang Y. (2007) Mitogen-activated protein kinases in heart development and diseases. Circulation 116: 1413–1423.
40. White M. Haddad H. Leblanc M.H. Giannetti N. Pflugfelder P. Davies R. et al. (2005) Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. J Heart Lung Transplant 24: 798–809.
41. White M. Ross H. Haddad H. LeBlanc M.H. Racine N. Pflugfelder P. et al. (2006) Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. Transplantation 82: 763–770.
42. Yamauchi J. Takai S. Matsushima-Nishiwaki R. Adachi S. Minamitani C. Natsume H. et al. (2009) Tacrolimus but not cyclosporine A enhances FGF-2-induced VEGF release in osteoblasts. Int J Mol Med 23: 267–272.
43. Yang C.W. Ahn H.J. Jung J.Y. Kim W.Y. Li C. Choi B.S. et al. (2003) Preconditioning with cyclosporine A or FK 506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia / reperfusion injury. Transplantation 75: 20–24.
44. Ye F. Ying-Bin X. Yu-Guo W. Hetzer R. (2009) Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis. J Heart Lung Transplant 28: 58–66.
45. Zhang W. (2002) Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. Cardiovasc Res 53: 294–303.
46. Zhen Y. Wang Y. Zhang W. Zhou C. Hui R. (2007) CardioSignal: a database of transcriptional regulation in cardiac development and hypertrophy. Int J Cardiol 116: 338–347.